| ★ | FIND-CKD Trial Poses Finerenone as a "Third Pillar" for Nondiabetic CKD | | 123 | Estados Unidos | |
| 14 | Global Burden of Chronic Kidney Disease : Causes and Prevention in Young Adults | Medical Centric Podcast @medicalcentric | — | Portugal | 83 |
| 19 | How Chronic Kidney Disease Impacts Brain Function | Medical Centric Podcast @medicalcentric | 1.1K | Portugal | 83 |
| 18 | Phase 3 VISIONARY: Sibeprenlimab May Preserve #KidneyFunction in IgA Nephropathy | | 981 | Estados Unidos | 83 |
| 5 | Diabetes Dialogue: Retatrutide Phase 3 Data Show Major Weight Loss | | 533 | Estados Unidos | 84 |
| 6 | SGLT2 EN ERC Beneficio en todos los estadios | ENSEÑANDO MEDICINA INTERNA @carloswaldomi | 383 | — | 84 |
| 13 | TRIUMPH-2: Retatrutide Reduces Weight, A1C in Patients With Obesity | | 350 | Estados Unidos | 84 |
| 15 | Hemodiálisis incremental como forma de inicio del tratamiento sustitutivo renal | Fundación Renal Española @fundacionrenale | 275 | España | 83 |
| 9 | Interim Phase 3 VISIONARY Data Show Sibeprenlimab Preserved Kidney Function in IgA Nephropathy | | 233 | Estados Unidos | 84 |
| 17 | Kidney Compass: VISIONARY 2-Year eGFR Data in IgA Nephropathy | | 199 | Estados Unidos | 83 |
| 4 | Retatrutide Cuts Weight, Cardiovascular Disease Risk in TRIUMPH-3 | | 158 | Estados Unidos | 84 |
| 2 | GLP-1 Receptor Agonists Reshape CKD Treatment Sequencing, With Pranav Garimella, MD | | 151 | Estados Unidos | 86 |
| 1 | FIND-CKD Expands Finerenone Evidence Beyond Diabetic CKD, With Rajiv Agarwal, MD | | 131 | Estados Unidos | 94 |
| 20 | AHA, ACC Release First-Ever Cardiovascular-Kidney-Metabolic Syndrome Guidelines | | 129 | Estados Unidos | 83 |
| 11 | Overcoming Barriers to Diagnosis of CKD in Type 2 Diabetes | | 116 | Alemania | 84 |
| 10 | VESALIUS-CV: Evolocumab Prevents Cardiovascular Disease in High-Risk Diabetes | | 96 | Estados Unidos | 84 |
| 8 | CALIBRATE: Encaleret Achieves Mineral Homeostasis in Patients With ADH1, With Rachel Gafni, MD | | 88 | Estados Unidos | 84 |
| 3 | GLP-1s Move Beyond Diabetes as Core Kidney-Protective Therapy | | 80 | Estados Unidos | 84 |
| 7 | Cardiovascular, Renal & Hematologic Pharmacology | Section 3 – Brenner & Stevens’ Pharmacology (6th) | Last Minute Lecture @lastminutelecture | 75 | Estados Unidos | 84 |
| 12 | Continuous Ketone Monitoring May Guide SGLT2i Use in T1D | | 33 | Estados Unidos | 84 |
| 16 | 30032022 - Unidad 3 - Fisiopatología de adultos - Casos de insuficiencia renal | Nancy Monzon @nancymonzon9782 | 0 | — | 83 |